Interleukin-6 and granulocyte-macrophage colony-stimulating factor are candidate growth factors for chronic myelomonocytic leukemia cells [PDF]
, 1989 MP Everson, CB Brown, MB Lilly
openalex +1 more source
CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 448-459, March 2025.Abstract Myelodysplastic syndromes (MDS) represent a group of bone marrow disorders involving cytopenias, hypercellular bone marrow, and dysplastic hematopoietic progenitors. MDS remains a challenge to treat due to the complex interplay between disease‐induced and treatment‐related cytopenias.
Neha Thakre +5 more
wiley +1 more source
مجله دانشگاه علوم پزشکی گرگان, 2017 Background and Objective: Granulocyte colony-stimulating factors (G-CSF) and its receptor express in developing follicles, fetal and reproductive tissues. The serum G-CSF concentration significantly increases during the ovulatory phase in comparison with
F Golshan, M Shahbazi, K Haidari
doaj
The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors [PDF]
, 1986 D Metcalf
openalex +1 more source
Granulocyte Colony-stimulating Factor-associated Aortitis
Internal Medicine, 2023 Nishioka, Hiroaki, Fujii, Mari
openaire +2 more sources
State‐of‐the‐Art on Model‐Informed Drug Development Approaches for Pediatric Rare Diseases
CPT: Pharmacometrics &Systems Pharmacology, EarlyView.ABSTRACT Pediatric rare diseases present unique challenges for drug development due to small patient populations, ethical constraints on clinical trial design, and limited prospectively defined natural history data. Model‐Informed Drug Development (MIDD) has emerged as a powerful paradigm to address these challenges by leveraging quantitative methods ...
Rajesh Krishna +4 more
wiley +1 more source
Divergent disease patterns in granulocyte-macrophage colony-stimulating factor transgenic mice associated with different transgene insertion sites. [PDF]
, 1988 D Metcalf, Jeffrey G. Moore
openalex +1 more source
Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis for febrile neutropenia in patients with non-Hodgkin's lymphoma in the United Kingdom (UK) [PDF]
Introduction: We report a cost-effectiveness evaluation of granulocyte colony-stimulating factors (G-CSFs) for prevention of febrile neutropenia (FN) following chemotherapy for non-Hodgkin’s lymphoma (NHL) in the United Kingdom (UK).
Akehurst, R. +3 more
core
Receptor for Granulocyte Colony-Stimulating Factor
Journal of Nutritional Science and Vitaminology, 1992 Rikirou Fukunaga, Shigekazu Nagata
openaire +4 more sources
Respirology, EarlyView.We developed a novel ICT with high clinical performance that can distinguish APAP patients from those with other pulmonary diseases. The rapid and simple detection of GMAbs in serum provided a new practical method for the diagnosis of APAP. ABSTRACT Background and Objectives Anti‐GM‐CSF autoantibodies (GMAbs) are essential biomarkers for diagnosing ...
Chika Narita +10 more
wiley +1 more source